Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: Results of the METADAP cohort

World Psychiatry

Volumn 14, Issue 3, 2015, Pages 366-367

  Corruble, Emmanuelle ^a,b,c,d   El Asmar, Khalil ^b   Trabado, Severine ^a,c,d,e   Verstuyft, Céline ^a,c,d,e   Falissard, Bruno ^a,b,c,f   Colle, Romain ^a,b,c,d   Petit, Anne Cécile ^b   Gressier, Florence ^a,b,c,d   Brailly Tabard, Sylvie ^a,c,d,e   Ferreri, Florian ^g,h   Lépine, Jean Pierre ⁱ   Haffen, Emmanuel ^j   Polosan, Mircea ^k   Bourrier, Céline ^b   Perlemuter, Gabriel ^a,c,e,l   Chanson, Philippe ^a,c,d,e   Fève, Bruno ^h,m   Becquemont, Laurent ^a,c,d,e  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSERM U1178   (France)

^c Service de chirurgie orthopédique et traumatologique Hôpitaux universitaires Paris Sud   (France)

^d BICÊTRE HOSPITAL   (France)

^e INSERM   (France)

^f HÔPITAL PAUL BROUSSE   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h HÔPITAL SAINT ANTOINE   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

^j UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^k GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^l HÔPITAL ANTOINE BÉCLÈRE   (France)

^m Imagine Institut Hospital Universitaire Necker   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SEROTONIN UPTAKE INHIBITOR; TRIACYLGLYCEROL; TRICYCLIC ANTIDEPRESSANT AGENT;

AGE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL (TOPIC); DRUG SAFETY; GENDER; GLUCOSE BLOOD LEVEL; HAMILTON DEPRESSION RATING SCALE; HUMAN; INCIDENCE; LETTER; MAJOR DEPRESSION; METABOLIC SYNDROME X; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84942524046     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20260     Document Type: Letter

References (9)

1. Pan A, Keum N, Okereke OI, et al., Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 2012; 35: 1171-80.
2. Vancampfort D, Correll CU, Wampers M, et al., Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables. Psychol Med 2013; 21: 1-12.
3. Rhee SJ, Kim EY, Kim SH, et al., Subjective depressive symptoms and metabolic syndrome among the general population. Prog Neuropsychopharmacol Biol Psychiatry 2014; 54: 223-30.
4. Rethorst CD, Bernstein I, Trivedi MH., Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES). J Clin Psychiatry 2014; 75: e1428-32.
5. Eckel RH, Grundy SM, Zimmet PZ., The metabolic syndrome. Lancet 2005; 365: 1415-28.
6. Mojtabai R, Olfson M., National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey. J Clin Psychiatry 2014; 75: 169-77.
7. Blumenthal SR, Castro VM, Clements CC, et al., An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry 2014; 71: 889-96.
8. Alberti KG, Zimmet P, Shaw J, et al., The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-62.
9. Fitzmaurice GM, Laird NM, Shneyer L., An alternative parameterization of the general linear mixture model for longitudinal data with non-ignorable drop-outs. Stat Med 2001; 20: 1009-21.